Homocysteine levels and coronary heart disease in Syria

R Joubran1, M Asmi, A Busjahn

  • 1Department of Clinical Laboratory Medicine, Faculty of the School of Pharmacy, Assad University Hospital, Damascus, Syria.

Insights

Elevated homocysteine levels are a significant independent risk factor for coronary artery disease in Arab men, even after accounting for other factors. Fibrinogen also emerged as an important cardiovascular risk factor in this population.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Epidemiology

Background:

  • Coronary artery disease (CAD) and dyslipidemia are prevalent in Arab countries.
  • Understanding cardiovascular risk factors is crucial for this demographic.

Purpose of the Study:

  • To investigate the role of homocysteine as a cardiovascular risk factor in Arab men.
  • To assess the association between homocysteine levels and angiographically confirmed coronary heart disease.

Main Methods:

  • A case-control study comparing 133 men with CAD to 130 age-matched asymptomatic controls.
  • Analysis included assessment of traditional risk factors, lipid profiles, fibrinogen, and homocysteine levels.

Main Results:

  • Men with CAD exhibited higher rates of hypertension, diabetes, and elevated levels of total cholesterol, LDL cholesterol, triglycerides, fibrinogen, and homocysteine.
  • Homocysteine levels were significantly higher in the CAD group (P < 0.05) and independently associated with CAD, even after adjusting for covariates (P < 0.006).
  • Fibrinogen and homocysteine levels correlated with the extent of coronary artery disease (number of vessels involved).

Conclusions:

  • Hyperhomocysteinemia is an independent risk factor for coronary artery disease in Arab men.
  • Fibrinogen concentrations are also identified as a significant risk factor in this population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...